Steven Cohen Verrica Pharmaceuticals Inc. Transaction History

Point72 Asset Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.88 - $8.51 $9,702 - $28,670	3,369 New	3,369 $21,000
Q3 2022 Nov 14, 2022	SELL	$2.17 - $4.3 $581,870 - $1.15 Million	-268,143 Reduced 35.57%	485,802 $1.42 Million
Q2 2022 Aug 15, 2022	BUY	$1.81 - $8.93 $1.36 Million - $6.73 Million	753,945 New	753,945 $1.45 Million
Q3 2019 Nov 15, 2019	SELL	$8.65 - $14.81 $1.23 Million - $2.11 Million	-142,206 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$7.1 - $11.62 $35,933 - $58,808	-5,061 Reduced 3.44%	142,206 $1.65 Million
Q1 2019 May 15, 2019	BUY	$7.95 - $14.07 $136,899 - $242,285	17,220 Added 13.24%	147,267 $1.59 Million
Q4 2018 Feb 14, 2019	BUY	$6.75 - $16.12 $270,317 - $645,557	40,047 Added 44.5%	130,047 $1.06 Million
Q3 2018 Nov 14, 2018	BUY	$13.94 - $19.88 $1.25 Million - $1.79 Million	90,000 New	90,000 $1.46 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.